Amer Zeidan, MBBS, MHS, associate professor of medicine, Yale University School of Medicine, joins the show to cover the latest exciting updates in the treatment landscapes for acute myeloid leukemia and myelodysplasia. The duo discuss the etiology of both malignancies, the intricacies of defining and diagnosing MDS, how patients become classified as either lower-risk or higher-risk MDS and the survival rates of both, concerns and consequences with iron overload during blood transfusions, and how transplant procedures have become safer for older patients. They then highlight the hot topics in MDS and AML as covered at the most recent ASH annual meeting.
N/A
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
